Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases

키워드

참고문헌 (42)

1. Anhê FF, "Bacteria to alleviate metabolic syndrome", Nat Med, 25, pp.1031~1033 (2019)
2. Depommier C, "Supplementation with Akkermansia muciniphila in overweight and obese human volunteers : a proof-of-concept exploratory study", Nat Med, 25, pp.1096~1103 (2019)
3. "Nat Med", 2017, 107~113
4. Everard A, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity", Proc Natl Acad Sci U S A, 110, pp.9066~9071 (2013)
5. Shen J, "Low-density lipoprotein receptor signaling mediates the triglyceride-lowering action of Akkermansia muciniphila in genetic-induced hyperlipidemia", Arterioscler Thromb Vasc Biol, 36, pp.1448~1456 (2016)
6. Li J, "Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-", -mice, 2016, pp.133, 2434~2446
7. Sakai T, "Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL", 6 mice fed a high-fat diet, 2013, pp.59, 144~147
8. Hernández MA, "The short-chain fatty acid acetate in body weight control and insulin sensitivity", Nutrients, 11, pp.1943~ (2019)
9. Canfora EE, "Short-chain fatty acids in control of body weight and insulin sensitivity", Nat Rev Endocrinol, 11, pp.577~591 (2015)
10. Zheng D, "Interaction between microbiota and immunity in health and disease", Cell Res, 30, pp.492~506 (2020)
11. Cani PD, "Metabolic endotoxemia initiates obesity and insulin resistance", Diabetes, 56, pp.1761~1772 (2007)
12. Ahmadi SF, "Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population", J Am Med Dir Assoc, 16, pp.933~939 (2015)
13. McClelland RL, "10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors : derivation in the MESA(Multi-Ethnic Study of Atherosclerosis)with validation in the HNR(Heinz Nixdorf Recall)study and the DHS(Dallas Heart Study)", J Am Coll Cardiol, 66, pp.1643~1653 (2015)
14. Greer RL, "Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism", Nat Commun, 7, pp.13329~ (2016)
15. Schertzer JD, "NOD1 activators link innate immunity to insulin resistance", Diabetes, 60, pp.2206~2215 (2011)
16. Amar J, "Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes : molecular mechanisms and probiotic treatment", EMBO Mol Med, 3, pp.559~572 (2011)
17. Hergott CB, "Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis", Blood, 127, pp.2460~2471 (2016)
18. Clarke TB, "Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity", Nat Med, 16, pp.228~231 (2010)
19. Hedl M, "Chronic stimulation of Nod2 mediates tolerance to bacterial products", Proc Natl Acad Sci U S A, 104, pp.19440~19445 (2007)
20. Denou E, "Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance", EMBO Mol Med, 7, pp.259~274 (2015)
21. Cavallari JF, "NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice", Am J Physiol Endocrinol Metab, 319, pp.E305~ (2020)
22. Grimm MC, "NOD2 mutations and Crohn's disease : are Paneth cells and their antimicrobial peptides the link?", Gut, 53, pp.1558~1560 (2004)
23. Jensen BA, "Microbial translocation in type 2 diabetes : when bacterial invaders overcome host defence in human obesity", Gut, 69, pp.1724~1726 (2020)
24. Cavallari JF, "Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4", Cell Metab, 25, pp.1063~1074 (2017)
25. Nishio H, "Nod1 ligands induce site-specific vascular inflammation", Arterioscler Thromb Vasc Biol, 31, pp.1093~1099 (2011)
26. Vlacil AK, "Deficiency of Nucleotide-binding oligomerization domain-containing proteins(NOD)1 and 2 reduces atherosclerosis", Basic Res Cardiol, 115, pp.47~ (2020)
27. Cavallari JF, "Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice", Am J Physiol Endocrinol Metab, 318, pp.E579~ (2020)
28. Croyal M, "Plasma trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes", J Clin Endocrinol Metab (2020)
29. Tang WH, "Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk", N Engl J Med, 368, pp.1575~1584 (2013)
30. Wang Z, "Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease", Nature, 472, pp.57~63 (2011)
31. Koeth RA, "Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis", Nat Med, 19, pp.576~585 (2013)
32. Zhu W, "Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk", Cell, 165, pp.111~124 (2016)
33. Li Z, "Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis", Lab Invest, 99, pp.346~357 (2019)
34. Wang G, "3, 3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice", J Nutr Biochem, 78, pp.108341~ (2020)
35. Seldin MM, "Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB", J Am Heart Assoc, 5, pp.e002767~ (2016)
36. Chen ML, "Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway", J Am Heart Assoc, 6, pp.e006347~ (2017)
37. Makrecka-Kuka M, "Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria", Toxicol Lett, 267, pp.32~38 (2017)
38. Heianza Y, "Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk", J Am Coll Cardiol, 75, pp.763~772 (2020)
39. Chen ML, "Resveratrol attenuates trimethylamine-N-oxide(TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota", MBio, 7, pp.e02210~ (2016)
40. Chen S, "Effects of probiotic supplementation on serum trimethylamine-N-oxide level and gut microbiota composition in young males: a double-blinded randomized controlled trial", Eur J Nutr (2020)[DOI]
41. Wang Z, "Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis", Cell, 163, pp.1585~1595 (2015)
42. Organ CL, "Nonlethal inhibition of gut microbial trimethylamine N-oxide production improves cardiac function and remodeling in a murine model of heart failure", J Am Heart Assoc, 9, pp.e016223~ (2020)

관련 논문AI추천